Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 26, 2013
Directly observed pegylated interferon plus self-administered ribavirin for the treatment of hepatitis C virus infection in people actively using drugs: a randomized controlled trialRobert J Hilsden, Gisela Macphail, Jason Grebely, et al.Canadian Liver Journal|August 22, 2022
Sociodemographic risk factors for hepatitis C virus infection in a prospective cohort study of 257 persons in Canada who inject drugsFaustyna Zietara, Pam Crotty, Michael Houghton, et al.Journal of Viral Hepatitis|January 9, 2025
Resistance-Associated Substitution Testing Trends and Impact on HCV Treatment Outcomes in Canada: A CanHepC-CANUHC AnalysisHimain Perera, Haris Imsirovic, Gisela Macphail, et al.Journal of Viral Hepatitis|August 13, 2024
Mixed-Genotype HCV Direct Acting Antiviral Outcomes: A CANUHC AnalysisHaris Imsirovic, Gisela Macphail, Brian Conway, et al.CMAJ Open|January 7, 2018
Real-world treatment of hepatitis C with second-generation direct-acting antivirals: initial results from a multicentre Canadian retrospective cohort of diverse patientsAlex I Aspinall, Abdel A Shaheen, Golasa S Kochaksaraei, et al.Canadian Liver Journal|August 22, 2022
Characterization of HCV-infected people who inject drugs (PWID) in the setting of clinical care in Canada (CAPICA): A retrospective studyBrian Conway, Julie Bruneau, Curtis Cooper, et al.Canadian Liver Journal|August 22, 2022
The Z-Profile Study: a multicenter, retrospective cohort study to assess the real-world use and effectiveness of elbasvir/grazoprevir in Canadian adult patients with chronic hepatitis CEdward Tam, Julie Tremblay, Chris Fraser, et al.The Lancet. Gastroenterology & Hepatology|March 30, 2023
Incidence of HIV and hepatitis C virus among people who inject drugs, and associations with age and sex or gender: a global systematic review and meta-analysisAdelina Artenie, Jack Stone, Hannah Fraser, et al.Pageof 1